DiagISN in short

Nordic Diagnostic Industry Stakeholders Network

The focus for DiagISN was to build a network of companies and selected non-commercial competence centres around issues of a high importance for Diagnostics Industry and in establishing diagnostic tools for pharmaceutical R&D. Among the key ambitions of DiagISN was to interact with development of pharmaceuticals, Biomarkers and Efficacy, the Innovative Medicines Initiative, FDAs draft to Drug-Diagnostics Co-Development concept paper are all examples of important areas that will be discussed.

Organization and Finance

Operative Managment:

SIK (Gunnar Hörnsten)

Steering Committee:

Kari Stenersen, Axis-Shield, Norway

Frank Mikkelsen, Biosense Laboratories AS, Norway

Helena Rudberg, Biovitrum, Sweden

Anita Herrström-Sjöberg, Cepheid AB, Sweden

Karl Johan Pluzek / Jon-Sverre Schanche, DAKO A/S, Denmark

Maria Anvret, Karolinska Institute, Sweden

Mia Bengtström, Pharma Industry Finland

Gunnar Hörnsten, SIK The Swedish Institute for Food and Biotechnology

Sveinbjorn Gizurarson, University of Iceland, Iceland

Finance:

Total ≈1,5 MSEK* (Industry and financial support from the Nordic Innovation Centre in 2006)

Duration: 2006-2007

Participants (in 2007):

Affibody AB	Dr Ludwig Brann Patentbyrå
Agrisera	EuroDiagnostica AB
AntibodyShop A/S	Hansa Medical AB
Athera Biotechnologies	IDL Biotech AB
Axis-Shield PoC AS	InDex Pharmaceuticals AB
Bactus AB	Invitrogen Corp.
BioBusiness Partners Scandinavia	Kem-En-Tec Diagnostics A/S
Biosense Laboratories AS	LifeAssays AB
Biotech IgG	Orion Diagnostica Oy
Biovitrum AB	Qiagen AB
Cepheid AB	SIK AB
Chempaq A/S	Uminova Innovation
Dako A/S	ViroGates
DiaGenic ASA	Vironova
DiaSorin AB	Zafena AB
Diatec Monoclonals AS	Åmic AB

Public meetings:

Discussion with health care providers, 1 November 2007, Stockholm, Sweden

Developing products intended for the Physicians-office-laboratories (POL) and Point-of-Care (POC) diagnostics, 13 June 2007, Stockholm, Sweden

From product development to sales - getting your product to the customer , September 29th, 2006, Copenhagen, Denmark

Commercialisation of research ideas and the early development of the company. Exemplified with ideas in the field of Biomarkers, May 29th 2006, Stockholm, Sweden

*exchange rates as of 2009-09-03